Delivery Order SPE2DB24D2205-SPE2DB24FDTET
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of TREMFYA 100 MG/ML SYRINGE medical supplies. The award, valued at $35,513.01, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $27,446.89 firm-fixed-price delivery order is for the supply of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product. The contract has an ultimate completion date of February 23, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,034.16 firm fixed price delivery order is for the supply of TREMFYA 100 MG/ML syringes. The contract has a period of performance through September 6, 2023 and was awarded on September 5, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to provide a comprehensive range of...
- This federal contract award is for $70,469.31 and was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order (SPE2DB20D1100|SPE2DB24FA3K8) for TREMFYA 100 MG/ML syringes, with a period of performance through February 22, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $9,413.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of TREMFYA 100 MG/ML INJECTORML, a pharmaceutical product, under a Firm Fixed Price Delivery Order contract. The contract has an ultimate completion date of December 6, 2023 and was awarded on December 5, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, the prime...
- This federal contract award, valued at $34,225.99, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TREMFYA 100 MG/ML syringes, with an ultimate completion date of November 9, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the procurement of TREMFYA 100 MG/ML SYRINGEML. The contract has a ceiling value of $28,889.61 and a period of performance through July 5, 2024. It is a delivery order contract with a firm-fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $10,891.12, is for the delivery of TREMFYA 100 MG/ML SYRINGE ML, a specialty pharmaceutical medication. This is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TREMFYA 100 MG/ML INJECTORML. The contract has a ceiling value of $18,547.25 and is a firm fixed-price delivery order with an ultimate completion date of April 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TREMFYA 100 MG/ML ONE-PRESSML, a medical product, with a ceiling value of $15,405.74 and a performance period ending on June 12, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB24FDTETDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TREMFYA 100 MG/ML SYRINGEML, a pharmaceutical product, with a total ceiling value of $15,876.58 and a period of performance ending on April 26, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. In addition to the DLA contract, Amerisourcebergen Drug Corp also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 4/25/24 |